Stockscreener 앱 받기
1.04%
전일 마감가:
$105.84
열려 있는:
$104.94
하루 거래량:
649.78K
Relative Volume:
0.73
시가총액:
$7.39B
수익:
$12.82B
순이익/손실:
$936.34M
주가수익비율:
9.7523
EPS:
10.74
순현금흐름:
$1.47B
1주 성능:
-6.02%
1개월 성능:
-11.19%
6개월 성능:
-25.30%
1년 성능:
-36.46%
1일 변동 폭
$104.20
$106.32
1주일 범위
$101.00
$111.72
52주 변동 폭
$101.00
$179.60
다비타 Stock (DVA) Company Profile
명칭
Davita Inc
전화
310-536-2668
주소
2000 16TH STREET, DENVER, CO
DVA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
DVA
Davita Inc
|
104.74 | 7.47B | 12.82B | 936.34M | 1.47B | 10.74 |
|
HCA
Hca Healthcare Inc
|
469.29 | 110.40B | 74.37B | 7.31B | 8.10B | 25.88 |
|
THC
Tenet Healthcare Corp
|
196.74 | 17.69B | 20.69B | 2.40B | 1.55B | 15.62 |
|
FMS
Fresenius Medical Care Ag Adr
|
21.95 | 12.54B | 21.23B | 924.30M | 2.22B | 1.2272 |
|
UHS
Universal Health Services Inc
|
199.88 | 12.76B | 16.08B | 1.20B | 1.06B | 17.82 |
|
ENSG
Ensign Group Inc
|
180.57 | 10.63B | 4.11B | 239.98M | 193.10M | 4.12 |
다비타 Stock (DVA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-03-06 | 개시 | Barclays | Equal Weight |
| 2023-08-07 | 업그레이드 | UBS | Neutral → Buy |
| 2022-11-01 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2022-10-31 | 다운그레이드 | UBS | Buy → Neutral |
| 2022-08-19 | 재개 | UBS | Buy |
| 2022-06-21 | 재확인 | BofA Securities | Underperform |
| 2021-09-10 | 개시 | Cowen | Market Perform |
| 2021-08-12 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2021-03-26 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2021-01-05 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2020-01-24 | 업그레이드 | Goldman | Neutral → Buy |
| 2019-11-07 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2019-10-25 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2019-09-11 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2019-07-26 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2019-01-08 | 업그레이드 | UBS | Sell → Neutral |
| 2019-01-03 | 개시 | Deutsche Bank | Buy |
| 2018-12-14 | 개시 | Barclays | Overweight |
| 2018-11-28 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2018-11-16 | 개시 | UBS | Sell |
| 2018-11-08 | 다운그레이드 | Raymond James | Strong Buy → Mkt Perform |
| 2018-09-13 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2018-01-04 | 업그레이드 | BofA/Merrill | Neutral → Buy |
| 2017-12-12 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2017-12-11 | 업그레이드 | Citigroup | Neutral → Buy |
| 2017-12-07 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2017-11-08 | 재확인 | RBC Capital Mkts | Sector Perform |
| 2017-10-09 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2017-06-26 | 다운그레이드 | Jefferies | Buy → Hold |
| 2016-12-13 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
모두보기
다비타 주식(DVA)의 최신 뉴스
Is DaVita (DVA) Pricing In Its Recent 37% One Year Share Price Gain? - Yahoo Finance UK
Is DaVita’s (DVA) Community Health Push Reframing Its Balance Between Patient Impact and Profitability? - Yahoo Finance
Here's what to expect from DaVita's next earnings report - MSN
FOMO Trade: Does DaVita Inc have strong fundamentalsMarket Activity Report & Verified Trade Idea Suggestions - baoquankhu1.vn
DaVita’s Stock Looks Cheap, But The Risks Are Real - Finimize
DaVitaIn the sweet spot of Growth and Value - Investing.com Canada
Here's What to Expect From DaVita's Next Earnings Report - Barchart.com
Is DaVita’s (DVA) Community Health Push Reframing Its Role In Long-Term Care Management? - Sahm
Behind Berkshire’s Curtain: Is Greg Abel Preparing to Cut Davita Loose? - Barchart.com
Davita stock hits 52-week low at $108.37 By Investing.com - Investing.com Nigeria
DaVita Inc (DVA) Trading Down 3.83% on Jan 13 - GuruFocus
DaVita Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
DaVita (NYSE:DVA) Reaches New 1-Year LowHere's What Happened - MarketBeat
Davita stock hits 52-week low at $108.37 - Investing.com
DaVita Inc. (DVA) Stock Analysis: Exploring the 28% Potential Upside in Healthcare’s Dialysis Leader - DirectorsTalk Interviews
DaVita Inc. (NYSE:DVA) Receives Consensus Rating of "Hold" from Analysts - MarketBeat
SG Americas Securities LLC Has $5.96 Million Stock Holdings in DaVita Inc. $DVA - MarketBeat
DaVita Inc.: How a Dialysis Giant Is Quietly Re?Engineering Kidney Care - AD HOC NEWS
The Truth About DaVita Inc.: Why Wall Street Is Watching While TikTok Sleeps On It - AD HOC NEWS
DaVita Inc. Stock Underperforms Friday When Compared To Competitors - 富途牛牛
Assessing DaVita (DVA) Valuation After Recent Share Price Weakness - Yahoo Finance
Will DaVita Inc. stock deliver compounding returns2025 Sector Review & Risk Controlled Stock Alerts - ulpravda.ru
Bank Watch: What downside risks could hit DaVita Inc. stockMarket Growth Report & Capital Protection Trade Alerts - Улправда
Is DaVita Inc. stock a top momentum playMarket Growth Report & Weekly Setup with High ROI Potential - ulpravda.ru
Is DaVita Inc. stock ready for breakout2025 Momentum Check & Safe Entry Point Identification - ulpravda.ru
National Branding Achieves Milestone of Over 1,700 Sign Projects with DaVita Kidney Care Using Sign and Branding Management Software - USA Today
How DaVita Inc. stock reacts to oil pricesMarket Volume Summary & Fast Moving Stock Trade Plans - ulpravda.ru
Will DaVita Inc. stock gain from strong economy2025 Earnings Surprises & Free AI Powered Buy and Sell Recommendations - Улправда
What technical signals suggest for DaVita Inc. stockJuly 2025 Earnings & Fast Entry Momentum Trade Alerts - ulpravda.ru
Will DaVita Inc. stock rally after Fed decisionsPortfolio Update Report & AI Powered Buy and Sell Recommendations - Улправда
What dividend safety rating applies to DaVita Inc. (TRL) stockEarnings Growth Summary & Verified Entry Point Detection - Улправда
Why DaVita HealthCare (DVA) Dipped More Than Broader Market Today - Yahoo Finance
Is DaVita stock underperforming the Dow? - MSN
DaVita (NYSE:DVA) Reaches New 1-Year Low After Analyst Downgrade - MarketBeat
DaVita HealthCare Partners stock hits 52-week low at $112.53 - Investing.com
Rockwell Medical extends DaVita supply agreement with price adjustment By Investing.com - Investing.com Australia
Rockwell Medical Extends DaVita Supply Agreement with Price Increase - TipRanks
Rockwell Medical extends DaVita supply agreement with price adjustment - Investing.com
A Look At DaVita (DVA) Valuation As Medicare Rules And Value-Based Kidney Care Progress - Sahm
What hedge fund activity signals for DaVita Inc stock2025 Analyst Calls & Verified Trade Idea Suggestions - moha.gov.vn
DaVita Stock: Analyst Estimates & Ratings - MSN
Downgrade Watch: What dividend safety rating applies to DaVita Inc TRL stockJuly 2025 Macro Moves & AI Enhanced Trading Alerts - moha.gov.vn
Caring for Caregivers: DaVita's Investment in Nursing Education and Growth - GuruFocus
Who Owns DaVita? Top Shareholders and Recent Insider Trades - TIKR.com
DaVita stock under the microscope: cautious optimism meets reimbursement risk - AD HOC NEWS
DaVita Inc Is Suddenly On Everyone’s Radar – But Is DVA Stock Actually Worth Your Money? - AD HOC NEWS
DaVita Inc. $DVA Shares Sold by Voya Investment Management LLC - MarketBeat
Risk Check: What dividend safety rating applies to DaVita Inc TRL stockDollar Strength & Step-by-Step Trade Execution Guides - moha.gov.vn
Dip Buying: Is MFAB stock a top hedge fund pickMarket Risk Analysis & Verified Short-Term Plans - moha.gov.vn
DaVita Expands Kidney Care Services with Global Healthcare Focus - Kalkine Media
DaVita (NYSE:DVA) Sets New 1-Year LowHere's What Happened - MarketBeat
다비타 (DVA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.53%
자본화:
|
볼륨(24시간):